Founder and CEO of ChemPass. Previously, Greg was CEO and CTO at ComInnex, Inc. (2012 - 2015) where he co-founded the company’s chemistry business and helped grow the operation to 40+ people, Prior, that he was the Managing Director and Director of Chemistry at AMRI Hungary for 4 years (2008 - 2012).
Between 2004 and 2008 he worked as a Senior Research Fellow at Merck & Co. in Rahway NJ supervising Merck’s Target Validation Chemistry group where he was responsible for developing Merck’s fragment-based lead discovery platform and its application to lead discovery programs. During 1998 - 2004 Greg held various managing positions at NeoGenesis Pharmaceuticals including Director of Library Development and Hit-to-Lead Optimization. He did his postdoctoral studies with Professor Garland Marshall in the Center of Drug Design at Washington University at St. Louis. Overall Greg spent 15 years in the United States where his groups contributed to the development of a Safety Assessment Candidate and a Preclinical Candidate.
Greg obtained a Ph.D. in medicinal chemistry from SUNY at Buffalo in 1996, and a M.S. (1991) and a B.S. (1989) degree in medicinal chemistry at the Budapest University of Technology and Economics.
Director of Chemistry
Co-founder and Head of Chemistry at ChemPass. Previously, Laszlo was the CEO at InFarmatik Kft. and InFarmatik, Inc. where he founded the company, initiated the chemistry business and instrument development then grew the operation to 20+ people. Prior, he was VP and Director of Chemistry at ComGenex Hungary for 6 years (1992 - 1998). Between 1982 and 1992 he worked as a Research Fellow at Gedeon Richter Chemical Works' process R&D group.
Meanwhile in the period between 2008 and 2014 Laszlo was co-founder and co-CEO of MediMass a medical device company with a core mass spectrometry technology (IKnife) for on line tissue analysis in surgery rooms. The company was acquired by Waters Corp. in 2014.
Laszlo obtained a doctor univ. degree in organic chemistry in 1994, and a M.S. (1982) and a B.S. (1980) degree in medicinal chemistry at the Budapest University of Technology and Economics.
Head of Software Development
Gabor is the Head of Software Development at ChemPass. Previously, he was the Head of IT and Software Development at ComCIX, Inc. (2011 – 2016) where he developed and commercialized an eNotebook-IT platform for the chemistry and pharmaceutical industries.
Prior, Gabor had a similar role as the Head of IT and Software Development at AMRI Hungary (2006 – 2011) and IT Manager and Director at ComGenex (1997 – 2006 where his team developed a highly integrated production platform for chemistry R&D and library production.
He obtained his engineer degree from the Technical University of Budapest in 1997.
Business Development Consultant
Laszlo is a Business Development Consultant for ChemPass. Laszlo is currently Managing Director at DBH Investment. His previous illustrious carrier includes following positions in Hungary: VP of Business Development at ComInnex, Inc. (2012 – 2016), the CEO at ThalesNano, Inc. (2007 – 2012), VP of Vice President of European Operations at AMRI Hungary (2006), and the CEO at ComGenex, Inc. (2001 – 2006).
In the US he was a research group leader at Neurex Corporation (US, - 2000) and Laszlo did his postdoc at the Wistar Institute in Philadelphia and at Brandeis University in Waltham, MA.
He is a Vice President of the Hungarian Association for Innovation and a Member of the Board of the Hungarian Biotechnology Association.